Literature DB >> 25496922

The relationship between gastrointestinal motility and gastric dilatation-volvulus in dogs.

Krista M Gazzola1, Laura L Nelson2.   

Abstract

Gastric dilatation-volvulus (GDV) is a devastating disease that most commonly affects large and giant-breed dogs. Though a number of risk factors have been associated with the development of GDV, the etiology of GDV remains unclear. Abnormal gastric motility patterns and delayed gastric emptying have been previously described in dogs following GDV. Work evaluating the effects of gastropexy procedures and changes to gastric motility after experimental GDV has not found the same changes as those found in dogs with naturally occurring GDV. Although the role of abnormal gastric motility in dogs with GDV will need to be clarified with additional research, such study is likely to be facilitated by improved access to and development of noninvasive measurement techniques for the evaluation of gastric emptying and other motility parameters. In particular, the availability of Food and Drug Administration-approved wireless motility devices for the evaluation of gastrointestinal motility is particularly promising in the study of GDV and other functional gastrointestinal diseases of large and giant-breed dogs. Published by Elsevier Inc.

Entities:  

Keywords:  gastropexy; motilin; wireless motility capsule; wireless motility device

Mesh:

Year:  2014        PMID: 25496922     DOI: 10.1053/j.tcam.2014.09.006

Source DB:  PubMed          Journal:  Top Companion Anim Med        ISSN: 1946-9837


  2 in total

1.  Diagnosis of chronic gastric instability using computed tomography in a Great Dane that progressed to gastric dilatation and volvulus: a literature review and case report.

Authors:  Peter Scott Czajkowski; Ruth Mackenzie Hallman
Journal:  Open Vet J       Date:  2018-06-29

2.  Laparoscopic repositioning of chronic gastric volvulus in a dog.

Authors:  Frans G Van Heerden; Marthinus J Hartman; Vanessa McClure; Robert M Kirberger
Journal:  J S Afr Vet Assoc       Date:  2018-11-06       Impact factor: 1.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.